🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Ziftomenib is an investigational drug in development for the treatment of p...
Status
Recruiting
Location
Mayo Clinic - Phoenix
Start Date
2023-07-18
Trial ID
NCT05735184
Treatments Being Tested
The purpose of this study is to improve upon the TINI study treatment. The ...
Status
Recruiting
Location
Phoenix Children's Hospital
Start Date
2023-11-03
Trial ID
NCT05848687
This is the first study to administer ziftomenib to Japanese patients. In t...
Status
Recruiting
Location
Chiba Aoba Municipal Hospital
Start Date
2026-04-23
Trial ID
NCT07623616
Treatments Being Tested
The objective of this observational study is to evaluate the efficacy and s...
Status
Recruiting
Location
The First Affiliated Hospital of Soochow University
Start Date
2025-11-01
Trial ID
NCT07559695
This phase II trial tests how well ziftomenib works in treating patients wi...
Status
Recruiting
Location
Ohio State University Comprehensive Cancer Center
Start Date
2026-10-01
Trial ID
NCT06930352
The primary objective of the study is to determine the recommended phase 2 ...
Status
Recruiting
Location
Children's Hospital Los Angeles
Start Date
2025-03-18
Trial ID
NCT06376162
Treatments Being Tested
To find the recommended dose of ziftomenib in combination with gemtuzumab o...
Status
Recruiting
Location
MD Anderson Cancer Center
Start Date
2025-03-07
Trial ID
NCT06448013
Treatments Being Tested
The purpose of this study is to test the safety, effects, and recommended d...
Status
Recruiting
Location
Massachusetts General Hospital
Start Date
2024-06-11
Trial ID
NCT06440135
Treatments Being Tested
The goal of this all-oral combination is to deliver safe and effective ther...
Status
Recruiting
Location
The University of Texas M. D. Anderson Cancer Center
Start Date
2025-07-10
Trial ID
NCT06769490
Treatments Being Tested
The goal of Phase 1 is to find the recommended dose of ziftomenib and oluta...
Status
Active Not Recruiting
Location
The University of Texas M. D. Anderson Cancer Center
Start Date
2026-05-28
Trial ID
NCT07411586
Treatments Being Tested